Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Clearing CBD As Dietary Ingredient? Legislation More Likely Than Rulemaking

Apr 02 2019

• By Malcolm Spicer

Related Content

FDA To Consider Regulatory Shift Making Cannabis Ingredients Officially Eligible For Use In Dietary Supplements

Dec 28 2018

DoJ Maintains Amarin 'Misplaced' Its Omega-3 Unfair Trade Argument

May 07 2018

To Curb PSE Diversion, Retailers Lead By Example With Emphasis On Tamper-Resistant Products

Sep 19 2014

Lack Of Supplement NDI Notification Guidance Not A Market Pass For Industry

Jun 29 2017

FDA Budget Request Signals Importance Of Boosting Food Safety Programs

Mar 19 2019

CBD Market Survival-Of-Fittest Looms With FDA Regulation, Industry Standards

Mar 25 2019

Health And Wellness Industry News: Restoring Access Bill Introduced, Another Dietary Fiber Meets FDA Definition, More

Mar 28 2019

House Appropriators Stoke Flames For FDA Regulation On CBD In Supplements

Mar 01 2019

Related Companies

Amarin Corp plc

Additional Topics

United States US States Advertising, Marketing & Sales Commercial Compliance Dietary Supplements Enforcement FDA Legislation Manufacturing OTC Drugs Policy Regulation Consumer

More from Marketing & Advertising

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window